Natera (NTRA) Cash from Financing Activities (2014 - 2026)
Natera's (NTRA) quarterly Cash from Financing Activities came in at $3.8 million in Q1 2026, up 590.81% YoY from $544000.0 in Q1 2025, and down 88.4% on a QoQ basis from $32.4 million in Q4 2025.
Natera (NTRA) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Natera (NTRA) has 13 years of Cash from Financing Activities data on file, last reported at $3.8 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 590.81% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.7 million (up 108.69% YoY) and the FY2025 annual result came in at $47.5 million, up 57.13% from the prior year.
- Cash from Financing Activities eased to $3.8 million in Q1 2026, from $32.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $468.2 million in Q4 2022 to a low of $544000.0 in Q1 2025.
- A 5-year average of $48.1 million and a median of $6.8 million in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 99.75% — and 2023, when it surged 16842.07%.
- Tracing NTRA's Cash from Financing Activities over 5 years: stood at $468.2 million in 2022, then tumbled by 98.54% to $6.8 million in 2023, then surged by 60.32% to $11.0 million in 2024, then surged by 195.3% to $32.4 million in 2025, then plunged by 88.4% to $3.8 million in 2026.
- The last three Cash from Financing Activities figures came in at $3.8 million (Q1 2026), $32.4 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 580.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.76 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 32.41 Mn |
| Dec 31, 2025 | 32.41 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 12.58 Mn |
| Jun 30, 2025 | 12.58 Mn |
| Mar 31, 2025 | 544,000.00 |
| Mar 31, 2025 | 544,000.00 |
| Dec 31, 2024 | 10.97 Mn |
| Dec 31, 2024 | 10.97 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 11.04 Mn |
| Jun 30, 2024 | 11.04 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Dec 31, 2023 | 6.85 Mn |